Issue 4/2018
Content (17 Articles)
Evaluation of potential antiplatelet effects of CSL112 (Apolipoprotein A-I [Human]) in patients with atherosclerosis: results from a phase 2a study
Paul A. Gurbel, Udaya S. Tantry, Denise D’Andrea, Thomas Chung, John H. Alexander, Kevin P. Bliden, Samuel D. Wright, Pierluigi Tricoci
An increased tendency in fibrinogen activity and its association with a hypo-fibrinolytic state in early stages after injury in patients without acute traumatic coagulopathy (ATC)
S. He, M. Blombäck, F. Boström, H. Wallen, J. Svensson, A. Östlund
Prothrombin complex concentrate for reversal of direct factor Xa inhibitors prior to emergency surgery or invasive procedure: a retrospective study
Siavash Piran, Caroline Gabriel, Sam Schulman
Impact of platelet reactivity on 5-year clinical outcomes following percutaneous coronary intervention: a landmark analysis
Fabio Mangiacapra, Iginio Colaiori, Elisabetta Ricottini, Antonio Creta, Giuseppe Di Gioia, Ilaria Cavallari, Edoardo Bressi, Marialessia Capuano, Emanuele Barbato, Germano Di Sciascio
Prothrombotic factors do not increase the risk of recurrent ischemic events after cryptogenic stroke at young age: the FUTURE study
Mijntje M. I. Schellekens, Mayte E. van Alebeek, Renate M. Arntz, Nathalie E. Synhaeve, Noortje A. M. M. Maaijwee, Hennie C. Schoonderwaldt, Maureen J. van der Vlugt, Ewoud J. van Dijk, Loes C. A. Rutten-Jacobs, Frank-Erik de Leeuw
Effectiveness and safety of oral anticoagulants in patients with sickle cell disease and venous thromboembolism: a retrospective cohort study
Megan Z. Roberts, G. Eric Gaskill, Julie Kanter-Washko, T. Rogers Kyle III, Brittany C. Jones, Nicole M. Bohm
Thrombosis in Philadelphia negative classical myeloproliferative neoplasms: a narrative review on epidemiology, risk assessment, and pathophysiologic mechanisms
Somedeb Ball, Kyaw Zin Thein, Abhishek Maiti, Kenneth Nugent
Impact of pre-admission treatment with non-vitamin K oral anticoagulants on stroke severity in patients with acute ischemic stroke
Carolin Hoyer, Alexandra Filipov, Eva Neumaier-Probst, Kristina Szabo, Anne Ebert, Angelika Alonso
Platelet response to direct thrombin inhibitor or fondaparinux treatment in patients with suspected heparin-induced thrombocytopenia
Tiffany K. Pon, Anjlee Mahajan, Aaron Rosenberg, Alpesh Amin, Digish Shah, Ian Jenkins, Vineet Gupta, Heather Hofmann, Anthony Bejjani, Richard White
Direct-acting oral anticoagulant drug level monitoring in clinical patient management
Amihai Rottenstreich, Netanel Zacks, Geffen Kleinstern, Bruria Hirsh Raccah, Batia Roth, Nael Da’as, Yosef Kalish
Direct oral anti-coagulants compared to vitamin-K antagonists in cardioversion of atrial fibrillation: an updated meta-analysis
Natale Daniele Brunetti, Nicola Tarantino, Luisa De Gennaro, Michele Correale, Francesco Santoro, Matteo Di Biase
Incidence and risk factors for acute kidney injury in patients with excessive anticoagulation on warfarin: a retrospective study
Siavash Piran, Hugh Traquair, Noel Chan, Marlene Robinson, Sam Schulman
No effectiveness of anticoagulants for thromboprophylaxis after non-major knee arthroscopy: a systemic review and meta-analysis of randomized controlled trials
Gang Zheng, Qian Tang, Ping Shang, Xiao-Yun Pan, Hai-Xiao Liu
The predictive value of the CHA2DS2-VASc score in patients with mechanical mitral valve thrombosis
Tufan Çınar, Mert Ilker Hayıroğlu, Veysel Ozan Tanık, Emre Aruğaslan, Muhammed Keskin, Mahmut Uluganyan, Ahmet Öz, Metin Çağdaş, Ahmet Taha Alper
Highlights from the Tenth International Symposium of Thrombosis and Anticoagulation (ISTA X), September 22 and 23, 2017, Salvador, Bahia, Brazil
Renato D. Lopes, Patricia O. Guimarães, Mark Crowther, Elaine Hylek, Gilson S. Feitosa-Filho, Luiz E. Ritt, Nivaldo Filgueiras, David A. Garcia
Acute agranulocytosis after oral administration of dabigatran: a rare case report and a short review of literature
Sergio Fasullo, Stefania Davì, Gioacchino Cosenza, Francesca Di Franco, Nicola La Manna, Alfonso Giubilato, Graziella Vetrano, Giorgio Maringhini